Umeclidinium bromide/vilanterol, sold under the brand name Anoro Ellipta, among others, is a

fixed-dose combination A combination drug or a fixed-dose combination (FDC) is a medicine that includes two or more active ingredients combined in a single dosage form. Terms like "combination drug" or "combination drug product" can be common shorthand for a FDC pr ...

medication for the treatment of

chronic obstructive pulmonary disease Chronic obstructive pulmonary disease (COPD) is a type of progressive lung disease characterized by long-term respiratory symptoms and airflow limitation. The main symptoms include shortness of breath and a cough, which may or may not produce ...

(COPD). It is administered by inhalation. The most common side effects include upper respiratory tract infections (nose and throat infection), urinary tract infections (infection of the structures that carry urine), pharyngitis (inflammation of the throat), sinusitis (inflammation of the sinuses), nasopharyngitis (inflammation of the nose and throat), headache, cough, oropharyngeal pain (pain in the mouth and throat), constipation and dry mouth. Text was copied from this source which is © European Medicines Agency. Reproduction is authorized provided the source is acknowledged. In 2020, it was the 254th most commonly prescribed medication in the United States, with more than 1million prescriptions.

References

External links

* Beta-adrenergic agonists Combination drugs Drugs acting on the respiratory system Long-acting beta2-adrenergic agonists Muscarinic antagonists GSK plc brands {{respiratory-system-drug-stub